Measurement of brain atrophy in subcortical vascular disease: A comparison of different approaches and the impact of ischaemic lesions

NeuroImage

Volumn 43, Issue 2, 2008, Pages 312-320

  O'Sullivan, Mike ^a   Jouvent, Eric ^b   Saemann, Philipp G ^c   Mangin, Jean Francois ^d   Viswanathan, Anand ^b,e   Gschwendtner, Andreas ^a   Bracoud, Luc ^f   Pachai, Chahin ^f   Chabriat, Hugues ^b   Dichgans, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HÔPITAL LARIBOISIÈRE   (France)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d DIF   (France)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BioClinica Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ACCURACY; ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENETIC MODEL; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PHYSICAL DISABILITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL PARAMETERS; VASCULAR DISEASE;

ADULT; AGED; ALGORITHMS; ATROPHY; BRAIN ISCHEMIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 53049087687     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.07.049     Document Type: Article

References (35)

1. Altman D.G., and Bland J.M. Measurement in medicine: the analysis of method comparison studies. The Statistician 32 (1983) 307-317
2. Anderson V.M., Fernando K.T., Davies G.R., Rashid W., Frost C., Fox N.C., and Miller D.H. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J. Neuroimaging 17 (2007) 61-68
3. Ashburner J., and Friston K.J. Voxel-based morphometry-the methods. Neuroimage 11 (2000) 805-821
4. Ashburner J., and Friston K.J. Unified segmentation. Neuroimage 26 (2005) 839-851
5. Auer D.P., Putz B., Gossl C., Elbel G., Gasser T., and Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 218 (2001) 443-451
6. Filippi M., Rovaris M., Inglese M., Barkhof F., De S.N., Smith S., and Comi G. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 1489-1496
7. Fox N.C., and Schott J.M. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 363 (2004) 392-394
8. Fox N.C., Cousens S., Scahill R., Harvey R.J., and Rossor M.N. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch. Neurol. 57 (2000) 339-344
9. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001) 21-36
10. Gootjes L., Teipel S.J., Zebuhr Y., Schwarz R., Leinsinger G., Scheltens P., Moller H.J., and Hampel H. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement. Geriatr. Cogn. Disord. 18 (2004) 180-188
11. Hartley S.W., Scher A.I., Korf E.S., White L.R., and Launer L.J. Analysis and validation of automated skull stripping tools: a validation study based on 296 MR images from the Honolulu Asia aging study. Neuroimage 30 (2006) 1179-1186
12. Horsfield M.A., Rovaris M., Rocca M.A., Rossi P., Benedict R.H., Filippi M., and Bakshi R. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J. Neurol. Sci. 216 (2003) 169-177
13. Jenkinson M., and Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5 (2001) 143-156
14. Jenkinson M., Bannister P., Brady M., and Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 (2002) 825-841
15. Jouvent E., Viswanathan A., Mangin J.F., O'Sullivan M., Guichard J.P., Gschwendtner A., Cumurciuc R., Buffon F., Peters N., Pachai C., Bousser M.G., Dichgans M., and Chabriat H. Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke 38 (2007) 1786-1790
16. Levy-Cooperman N., Ramirez J., Lobaugh N.J., and Black S.E. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis. Stroke. 39 (2008) 1134-1141
17. Maclullich A.M., Wardlaw J.M., Ferguson K.J., Starr J.M., Seckl J.R., and Deary I.J. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1519-1523
18. Mangin J.F. Entropy minimization for automatic correction of intensity nonuniformity. IEEE Work (2000), MMBIA. IEEE Press, Hilton Head Island, South Carolina 162-169
19. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le G.G., Boomsma D., Cannon T., Kawashima R., and Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 (2001) 1293-1322
20. Miller D.H. Brain atrophy, interferon beta, and treatment trials in multiple sclerosis. Lancet 364 (2004) 1463-1464
21. Miller D.H., Barkhof F., Frank J.A., Parker G.J., and Thompson A.J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125 (2002) 1676-1695
22. Miller D.H., Soon D., Fernando K.T., MacManus D.G., Barker G.J., Yousry T.A., Fisher E., O'Connor P.W., Phillips J.T., Polman C.H., Kappos L., Hutchinson M., Havrdova E., Lublin F.D., Giovannoni G., Wajgt A., Rudick R., Lynn F., Panzara M.A., and Sandrock A.W. MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 68 (2007) 1390-1401
23. O'Sullivan M., Jarosz J.M., Martin R.J., Deasy N., Powell J.F., and Markus H.S. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56 (2001) 628-634
24. O'Sullivan M., Morris R.G., Huckstep B., Jones D.K., Williams S.C., and Markus H.S. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J. Neurol. Neurosurg. Psychiatry 75 (2004) 441-447
25. O'Sullivan M., Ngo E., Viswanathan A., Jouvent E., Gschwendtner A., Saemann P.G., Duering M., Pachai C., Bousser M.G., Chabriat H., and Dichgans M. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol. Aging (2007) Oct 24. [Epub ahead of print]
26. Pelletier D., Garrison K., and Henry R. Measurement of whole-brain atrophy in multiple sclerosis. J. Neuroimaging 14 (2004) 11S-19S
27. Peters N., Holtmannspotter M., Opherk C., Gschwendtner A., Herzog J., Samann P., and Dichgans M. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 66 (2006) 1517-1522
28. Riviere D., Regis J., Cointepas Y., Papadopoulos-Orfanos D., Cachia A., and Mangin J.F. A freely available Anatomist/BrainVISA package for structural morphometry of the cortical sulci. Neuroimage. 19 (2003) 934
29. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002) 143-155
30. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., and De S.N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 17 (2002) 479-489
31. Smith S.M., Rao A., De S.N., Jenkinson M., Schott J.M., Matthews P.M., and Fox N.C. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage. 36 (2007) 1200-1206
32. Sormani M.P., Rovaris M., Valsasina P., Wolinsky J.S., Comi G., and Filippi M. Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis. Neurology 62 (2004) 1432-1434
33. Trip S.A., Schlottmann P.G., Jones S.J., Li W.Y., Garway-Heath D.F., Thompson A.J., Plant G.T., and Miller D.H. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31 (2006) 286-293
34. Viswanathan A., Guichard J.P., Gschwendtner A., Buffon F., Cumurcuic R., Boutron C., Vicaut E., Holtmannspotter M., Pachai C., Bousser M.G., Dichgans M., and Chabriat H. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 129 (2006) 2375-2383
35. Wen W., and Sachdev P.S. Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke study. Stroke 35 (2004) 2813-2819